400 related articles for article (PubMed ID: 26226195)
1. Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?
Keijzers M; Damoiseaux J; Vigneron A; Bodart N; Kessels A; Dingemans AM; Hochstenbag M; Maessen J; De Baets M
Autoimmunity; 2015; 48(8):552-5. PubMed ID: 26226195
[TBL] [Abstract][Full Text] [Related]
2. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
Ambrogi V; Mineo TC
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of infrasternal mediastinoscopic thymectomy in myasthenia gravis.
Murai H; Uchiyama A; Mei FJ; Kojima M; Kira J
J Neurol Sci; 2009 Dec; 287(1-2):185-7. PubMed ID: 19726063
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.
Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
Muscle Nerve; 2018 Dec; 58(6):796-800. PubMed ID: 30020542
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.
Yang J; Liu C; Li T; Li C
Int J Neurosci; 2017 Sep; 127(9):785-789. PubMed ID: 27819773
[TBL] [Abstract][Full Text] [Related]
7. Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes.
Keijzers M; de Baets M; Hochstenbag M; Abdul-Hamid M; Zur Hausen A; van der Linden M; Kuks J; Verschuuren J; Kessels F; Dingemans AM; Maessen J
Eur J Cardiothorac Surg; 2015 Jul; 48(1):40-5. PubMed ID: 25234092
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of quantitative antibodies measurement in blood serum by interaction with muscle acetylcholine receptor domain in myasthenia patients].
Gekht BM; Lantsova VB; Sepp EK
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(2):34-7. PubMed ID: 12674702
[TBL] [Abstract][Full Text] [Related]
9. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
11. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
[TBL] [Abstract][Full Text] [Related]
12. [Thymectomy and antibodies to acetylcholine receptors (AChR) in patients with myasthenia gravis in the early postoperative period].
Nikishov VN; Bogdanov EI; Sanadze AG; Sigal EI; Sidnev DV; Dedaev SI; Kondrat'ev AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):32-6. PubMed ID: 23235409
[TBL] [Abstract][Full Text] [Related]
13. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
[TBL] [Abstract][Full Text] [Related]
14. Assessment of pre and post-thymectomy myasthenia gravis.
Bokoliya SC; Patil SA
Neurol Res; 2019 Mar; 41(3):275-281. PubMed ID: 30574849
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of patients with Myasthenia gravis from the Henan province, China.
Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune myasthenia gravis, immunotherapy and thymectomy in children.
Ware TL; Ryan MM; Kornberg AJ
Neuromuscul Disord; 2012 Feb; 22(2):118-21. PubMed ID: 21911294
[TBL] [Abstract][Full Text] [Related]
17. Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis.
Uzawa A; Kawaguchi N; Kanai T; Himuro K; Oda F; Yoshida S; Yoshino I; Kuwabara S
J Neurol; 2015; 262(4):1019-23. PubMed ID: 25683765
[TBL] [Abstract][Full Text] [Related]
18. [Thymectomy and muscle antibodies in myasthenia gravis].
Romi F; Gilhus NE; Aarli JA
Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
[TBL] [Abstract][Full Text] [Related]
19. Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis.
Jiang R; Hoehn KB; Lee CS; Pham MC; Homer RJ; Detterbeck FC; Aban I; Jacobson L; Vincent A; Nowak RJ; Kaminski HJ; Kleinstein SH; O'Connor KC
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30649-30660. PubMed ID: 33199596
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
